Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
MRC Technology & Yabao Pharmaceuticals Announce Exclusive Partnership December 2, 2014
MRC Technology and Yabao Pharmaceutical Co, Inc. recently announced an exclusive license agreement to discover, develop, and commercialize innovative compounds...NANOTECHNOLOGY MARKET - Nanotechnology Markets in Healthcare & Medicine November 19, 2014
Kevin James, Jackson Highsmith, and Paul Evers report the global market for nanoparticles in the life sciences is estimated at over $29.6 billion for 2014. This market is forecast to grow to more than $79.8 billion by 2019, to register a healthy compound annual growth rate of 22%. The biggest increase will come in the area of drug delivery systems.
Capsugel Advances First Intrinsically Enteric Capsule Technology November 10, 2014
Capsugel recently announced the expansion of its lead-user customer-collaboration program for its intrinsically enteric capsule technology. This breakthrough drug delivery...VACCINE TECHNOLOGY - Vaccine Technologies & the Rationale for New Nanoparticle Formulations October 3, 2014
Robert S. Becker, PhD, MBA, and Mark A. Mitchnick, MD, explain how SATx technology provides a new flexible formulation platform for the generation of nanoparticulate vaccine formulations without the limitations of previous formulation technologies that have inhibited the optimization of vaccine potencies and safety profiles.
FORMULATION DEVELOPMENT - Solumerized(TM) Trans-Resveratrol, Bridging the Bioenhancement Gap to Drug Delivery Between Pharmaceuticals & Dietary Supplements October 2, 2014
Amir Zalcenstein, PhD, Galia Temtsin Krayz, PhD, and Sabina Glozman, PhD, discuss the example of Resveratrol, a supplement with a solid body of scientific data attesting to its efficacy in enhancing lifespan and treating a variety of medical conditions, which yet remains short of its true market potential due to stability, bioavailability, and cost issues.
NANOEMULSION FORMULATIONS - Nanoemulsion Formulations for Injection & Oral Administration October 2, 2014
Troy M. Harmon, MS, MBA, and Jingjun Huang, PhD, use Ascendia’s EmulSol technology to develop a novel oil-in-water nanoemulsion formulation of clopidogrel whereby the free-base form of clopidogrel has acceptable solubility in the oil phase, and is protected from chemical degradation.
Global Market for Nanoparticles in Biotechnology & Pharmaceuticals to Reach $79.8 Billion September 14, 2014
The nanoparticle drug/delivery market presents an increasingly significant part of the overall pharmaceutical product market worldwide. The most rapid advances have...Ascendia Advances, Successfully Applies Nano-Emulsion Technology Platform September 9, 2014
Ascendia Pharmaceuticals, a start-up specialty pharmaceutical company in the business of providing formulation technologies and product development services for poorly...PARENTERAL CONTAINERS - A Novel Approach to Mitigating Oxygen Permeation in Prefilled Syringes September 3, 2014
Peter Sagona, MS, Rómulo Romero, MS, and Adam Breeland report that biological systems are entering the market place at an increased rate, and thus focus on the importance of designing a primary container system (prefilled syringe) for the minimization of oxygen exposure to the drug product.
SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: Early-Stage Partnerships Are On The Rise April 2, 2014
Contributor Cindy H. Dubin asked leading CMOs and CDMOs to describe the value-added services they offer with respect to formulation and manufacturing. Solving challenges of insufficient solubility, poor stability, identifying excipient candidates, and particle design topped their list of offerings.
Marina Biotech Strengthens IP Estate for SMARTICLES Nucleic Acid Delivery Technology January 15, 2014
Marina Biotech, Inc. recently announced the grant and issuance of patents relating to the company's proprietary nucleic-acid delivery technology, SMARTICLES....IBM Research & Institute of Bioengineering & Nanotechnology Discover Breakthrough for Breast Cancer Delivery December 2, 2013
Recently, scientists from IBM and Singapore's Institute of Bioengineering and Nanotechnology published a breakthrough drug delivery technique, demonstrating the first...MARKET BRIEF - The Market for Type 2 Diabetes Therapeutics - Key Findings From a Recent Analysis of Global Drug Development Efforts November 19, 2013
Debbie Toscano, Senior Industry Analyst, Frost & Sullivan, summarizes key findings of Frost & Sullivan’s recent analysis of the type 2 diabetes therapeutics market, which examines in detail the insulin and non-insulin segments of this market on a global level.
FORMULATING PEPTIDES - Novel Formulations for Non-Invasive Delivery & Stabilization of Peptides October 15, 2013
Edward T. Maggio, PhD, examines how alkylsaccharides offer exciting prospects for novel formulations, providing non-invasive delivery, stabilization, and immunogenicity reduction for biotherapeutic products, resulting in broader patient acceptance and compliance and an increase in their acceptance as viable commercial pharmaceuticals.
Adamis Pharmaceuticals Signs Agreement to Acquire 3M’s Technology August 11, 2013
Adamis Pharmaceuticals Corporation recently announced it has entered into an agreement to exclusively license and, with additional payment, fully acquire...LIPOSOME PREPARATION TECHNOLOGY - Freeze Fracture Electron Microscopic (ff EM) Examination & Analysis of Liposomes Produced by Covaris AFA Technology June 10, 2013
Srikanth Kakumanu, PhD, and Rajeev A. Jain, PhD, explain how an alternative ultrasonic processing technology allows manufacturing of liposomes of predetermined sizes and offers an efficient, isothermal, and non-contact process.
ORALLY DISINTEGRATING TABLETS - Novel Controlled Release Formulation for Orally Disintegrating Tablets Using Ion Exchange Resins June 10, 2013
Abhijit Gokhale, PhD, and Praba Sundararajan indicate that drugs not typically amenable to ODT formulations include those that present taste-masking difficulties or require controlled or sustained release. However, as the demand for ODTs continues to grow, formulation scientists are exploring ways to adapt ODT formulations for drugs that require controlled or sustained release for optimal therapeutic benefits.
Recipharm & Synthonics Join Forces to Promote Delivery Technology May 14, 2013
Recipharm Pharmaceutical Development AB and Synthonics, Inc. recently announced the formation of a Joint Promotion Agreement. The contract, the first...Imugene Granted Patent for Novel Delivery Technology May 6, 2013
Australian drug delivery technology company Imugene recently announced the acceptance of a key Chinese patent application for the company’s novel...FORMULATION DEVELOPMENT - Trends & Opportunities in Particle Design Technologies - Life Sciences & Biopharma in the Spotlight April 30, 2013
Frost & Sullivan Analyst, Cecilia Van Cauwenberghe, MS, examines the observed trends in particle design and engineering technologies, as well as the main factors and opportunities driving the principal technological advances in the biopharmaceutical industry.
Company Profiles
Lyophilization Technology, Inc.
Lyophilization Technology, Inc. 30 Indian Drive Ivyland, PA 18974-1431 T: (215) 396-8373 F: (215) 396-8375 E: inquiry@lyo-t.com W: www.lyotechnology.com WHO...CycloLab Cyclodextrin Research & Development Ltd.
CycloLab Cyclodextrin Research & Development Ltd. E: commerce@cyclolab.hu W: cyclolab.hu LinkedIn: https://www.linkedin.com/company/10040240 For more than 30 years, Cyclolab Ltd. has been involved in...
